Erlotinib Hydrochloride | |
---|---|
Trade Name | Tarceva |
Orphan Indication | Malignant gliomas |
USA Market Approval | USA |
USA Designation Date | 2003-07-18 00:00:00 |
Sponsor | Genentech, Inc;1 DNA Way;South San Francisco, California, 94080 |
Erlotinib Hydrochloride | |
---|---|
Trade Name | Tarceva |
Orphan Indication | Malignant gliomas |
USA Market Approval | USA |
USA Designation Date | 2003-07-18 00:00:00 |
Sponsor | Genentech, Inc;1 DNA Way;South San Francisco, California, 94080 |